By contrast, the tumors in the mice treated with shark cartilage showed about a 40 percent shrinkage between day fourteen and day twenty one because they were unable to nourish themselves. Further research has demonstrated that the destruction of tu mor tissue is exponentially related to the reduction of vascular ization.12 Her research shows that the destruction or preven tion of a single capillary segment led to the death or inhibition of thousands of tumor cells. On December 26, 1991. Dr. William Lane, the author of the book, Sharks Don't Get Cancer was granted a U.S. Patent covering the use of shark cartilage to inhibit angiogenesis. This patent was fully supported by a CAM assay and by showing the inhibition of angiogenesis by Shark Cartilage.
Additional patents are underway.
Many patients experienced tumor regression, reduction or cessation of pain and improvement in appetite, attitude and quality of life. In a study involving 76 Cancer patients of a New Jersey physi cian, all 76 patients responded to Shark Cartilage Therapy. The Shark Cartilage Therapy was shown to work on all solid tu mors, but appeared to be most effective with breast, liver, brain and esophageal tumors, where major changes within four to six weeks were noticeable. Lung and prostate cancer seemed to respond more slowly. Some good responses were observed with pancreatic tumors when very high dosage levels were ad ministered.17 Shark Cartilage Therapy was shown to work on all solid tu mors, but appeared to be most effective with breast, liver, brain and esophageal tumors, where major changes within four to six weeks were noticeable.